---
title: "Elotuzumab - Multiple myeloma"
sidebar: mydoc_sidebar
permalink: db06317-mesh-d009101-1.html
toc: false 
---


Path ID: `DB06317_MESH_D009101_1`
{% include image.html url="images/db06317-mesh-d009101-1.png" file="db06317-mesh-d009101-1.png" alt="db06317-mesh-d009101-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C546027 | Elotuzumab | Drug |
| UniProt:Q9NQ25 | SLAM family member 7 | Protein |
| CL:0000623 | Natural killer cell | Cell |
| GO:0001788 | Antibody-dependent cellular cytotoxicity | BiologicalProcess |
| GO:0008219 | Cell death | BiologicalProcess |
| MESH:D009101 | Multiple myeloma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Elotuzumab | INCREASES ACTIVITY OF | Slam Family Member 7 |
| Slam Family Member 7 | EXPRESSED IN | Natural Killer Cell |
| Natural Killer Cell | CAPABLE OF | Antibody-Dependent Cellular Cytotoxicity |
| Antibody-Dependent Cellular Cytotoxicity | PRECEDES | Cell Death |
| Cell Death | NEGATIVELY CORRELATED WITH | Multiple Myeloma |
|---------|-----------|---------|

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/27695618/](https://pubmed.ncbi.nlm.nih.gov/27695618/)
  - [https://go.drugbank.com/drugs/DB06317#BE0003492](https://go.drugbank.com/drugs/DB06317#BE0003492)
